Antipsychotic drug use and mortality in older adults with dementia.
about
Pharmacological interventions for the treatment of delirium in critically ill patientsPsychosocial interventions for reducing antipsychotic medication in care home residentsAntidepressants for agitation and psychosis in dementiaPsychosocial interventions for reducing antipsychotic medication in care home residentsAntidepressants for agitation and psychosis in dementiaIncreasing off-label use of antipsychotic medications in the United States, 1995-2008Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic ReviewApplications of propensity score methods in observational comparative effectiveness and safety research: where have we come and where should we go?Pharmacological and nonpharmacological management of delirium in critically ill patients.Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersAssessment and management of behavioral and psychological symptoms of dementiaDifferential impact of two risk communications on antipsychotic prescribing to people with dementia in Scotland: segmented regression time series analysis 2001-2011Testing family-centered, function-focused care in hospitalized persons with dementia.Can agitated behavior of nursing home residents with dementia be prevented with the use of standardized stimuli?Psychotropic medication use among nursing home residents in Austria: a cross-sectional study.Packages of care for dementia in low- and middle-income countries.Psychiatric Aspects of Dementia.Pharmaceutical Use and Spending Trend in Medicare Beneficiaries With Dementia, From 2006 to 2012.Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study.Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions.Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warningsAntipsychotic use varies by patient age.Impact of prescribed medications on patient safety in older people.Patterns and trends in antipsychotic prescribing for Parkinson disease psychosisInstrumental variable applications using nursing home prescribing preferences in comparative effectiveness researchDaily medication use in nursing home residents with advanced dementia.Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis.Clinical pharmacology and vascular risk.Impact of FDA black box advisory on antipsychotic medication usePharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review.Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home SurveyPharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.The geriatric population and psychiatric medicationSafety and efficacy of antipsychotic drugs for the behavioral and psychological symptoms of dementia.Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units.Psychotropic medication use among elderly nursing home residents in Slovenia: cross-sectional study.Risk of mortality among individual antipsychotics in patients with dementiaRisk of mortality (including sudden cardiac death) and major cardiovascular events in atypical and typical antipsychotic users: a study with the general practice research database.Movement disorders in elderly users of risperidone and first generation antipsychotic agents: a Canadian population-based study
P2860
Q24187548-7CAD3D43-8DBA-48D6-A774-AD5EC795C49CQ24202168-E9D9FD89-E412-4133-811F-88F97089079CQ24236550-31CC5408-BB4A-4FE6-B041-5260E6100AC9Q24236669-F3F0CE2A-3487-4A76-A56D-8D8C21AB5680Q24241426-76BE41E7-80AB-44A2-B0D1-63FC2A360034Q24628874-59E11951-1A54-433F-9460-EAABBEDEC978Q26773524-D8744FD0-F3F5-4C6D-B4BA-2EBE63A11D1FQ26849372-A7B46597-06E4-4B5F-B472-B0684FC9E899Q27005223-C814ACF7-B8F8-4331-91EA-20253CA93420Q27009995-C9522CEF-2902-4CF4-BD98-849C903E6698Q28088782-6E55F534-AA38-4025-8B68-D3F878ECE59FQ28534696-C4B5D306-A501-40B5-A9B9-81B857916010Q30203277-B2199790-A4DF-4A9E-B344-45DEBFD80E39Q30390736-53AE3C52-1B03-4D3B-8070-ECB2FA03FFB5Q33449888-E8F26622-0E21-4589-80E2-EC799BD56F75Q33514859-F18CBFA3-A07F-468E-89EF-E8AE50ACA8DCQ33562417-65975922-7CD9-471E-A757-72B47A3FBBA5Q33610481-8408289C-EC61-4349-81F5-E425ADCE7938Q33736204-DE6465E2-08A4-44A6-8E90-46FF08FF8698Q33787145-2CBEE742-5DA8-4C90-98F1-D6C87BF326B0Q33888723-1FDDAB42-F6DD-42E6-9188-C4F0441B506BQ33894639-55F402FA-4DE6-4B76-AA28-6E605EF798D3Q33949432-C0E095DE-0D20-4A3F-9489-D9BF517292ECQ33957582-BFB6F217-724F-44BA-93A6-E4FB161B5EDEQ33976565-247F259A-3976-49DC-A3F4-982369A03D8CQ34020509-DDA997FE-6D91-48C2-B7A9-3F45028B21D6Q34070862-85CC85F8-BFF7-4AE6-B67C-DDE574A47343Q34072168-6AE0F2D6-1527-48BF-A085-9E3C8EA32A45Q34092198-7EDB44FD-E39E-4C73-8CDA-AF502BC57DF6Q34274859-A389D0EB-E946-45F9-99EA-94C36365A2C5Q34298335-88066D7B-F2DF-47EE-8884-8B433C6794E7Q34436679-28B9347D-2585-4558-B704-BF4DF120555AQ34452896-A020A147-2079-4519-91CB-A6862CC64DEEQ34543911-A7FCD3A4-80B4-415F-A289-28AD24143219Q34571959-7C45760E-0464-4673-B1F0-9ECD04ED74EFQ34580523-A81AA3AD-B873-42DE-BBB9-B1FC1C8C9D9BQ34613842-16B7CD72-5B52-48AD-A8CA-38D0D44B85A3Q34634590-3DB6218C-8D42-40E2-9F2E-CE3246678174Q34659165-DD3DDAC0-7978-477A-A75E-CE3606A5A4A2Q34734083-3490E86D-B812-40CF-B438-5D436DCF34AC
P2860
Antipsychotic drug use and mortality in older adults with dementia.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Antipsychotic drug use and mortality in older adults with dementia.
@ast
Antipsychotic drug use and mortality in older adults with dementia.
@en
Antipsychotic drug use and mortality in older adults with dementia.
@nl
type
label
Antipsychotic drug use and mortality in older adults with dementia.
@ast
Antipsychotic drug use and mortality in older adults with dementia.
@en
Antipsychotic drug use and mortality in older adults with dementia.
@nl
prefLabel
Antipsychotic drug use and mortality in older adults with dementia.
@ast
Antipsychotic drug use and mortality in older adults with dementia.
@en
Antipsychotic drug use and mortality in older adults with dementia.
@nl
P2093
P1476
Antipsychotic drug use and mortality in older adults with dementia.
@en
P2093
Chaim M Bell
Geoffrey M Anderson
Hadas D Fischer
Jerry H Gurwitz
Kathy Sykora
Kelvin Lam
Nathan Herrmann
Paula A Rochon
Philip E Lee
Sharon-Lise T Normand
P304
P356
10.7326/0003-4819-146-11-200706050-00006
P407
P577
2007-06-01T00:00:00Z